From: miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
Cell lines | Histology | EGFR mutation | IC50 of gefitinib (μM) |
---|---|---|---|
PC-9 | AD | E746-A750 del | 0.047 ± 0.012 |
NCI-H820 | AD | E746-E749 del | 2.783 ± 0.854 |
NCI-H2170 | SQ | WT | 4.254 ± 0.752 |
A549 | AD | WT | 9.172 ± 1.228 |
NCI-H1650 | AD | E746-A750 del | 10.473 ± 2.164 |
NCI-H1993 | AD | WT | 16.432 ± 0.965 |
NCI-H2126 | LC | WT | 23.179 ± 2.843 |
NCI-H1975 | AD | L858R | 26.748 ± 3.386 |
NCI-H1299 | LC | WT | 28.637 ± 2.512 |
NCI-H1648 | AD | WT | 38.425 ± 1.838 |
NCI-H1703 | SQ | WT | 41.258 ± 5.217 |
NCI-H2347 | AD | WT | 62.417 ± 4.658 |